Silver Book

Silver Book Fact

Over 6 years, flu vaccine prevented ~13 million cases

Over a 6-year period (2005 – 2011), the influenza vaccine prevented an estimated 13 million influenza cases–between 1.1 million and 5 million annually.

Kostova, Deliana, Carrie Reed, Lyn Finelli, Po-Yung Cheng, Paul M. Gargiullo, et al. Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011. PLoS ONE. 2013; 8(6): e66312. doi:10.1371/journal.pone.0066312. http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0066312

Reference

Title
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011
Publication
PLoS ONE
Publication Date
2013
Authors
Kostova, Deliana, Carrie Reed, Lyn Finelli, Po-Yung Cheng, Paul M. Gargiullo, et al.
Volume & Issue
Volume 8, Issue 6
Pages
e66312. doi:10.1371/journal.pone.0066312.
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Staff flu vaccination reduces incidence of staff and patients
    Vaccination of staff in a tertiary care facility over a period of 12 influenza seasons increased vaccination coverage from 4% to 67%, reduced laboratory-confirmed cases of influenza amongst staff from…  
  • Shingles vaccine could improve QALY and save money
    Vaccination of 1 million people age 60 and over with the shingles vaccine would result in 11,919 non-discounted and 8,782 discounted QALYs (quality of life years) gained and save around…  
  • Potential savings from shingles vaccine
    Use of the shingles vaccine in immunocompetent adults ages 60 and older could save between $82 and $103 million in healthcare costs associated with the diagnosis and treatment of shingles,…  
  • Reduction of central-line infections saved ~ 1,800 lives and $280 million
    Standardization of best practice interventions reduced central line-associated blood stream infections and saved an estimated 1,800 lives and $280 million.  
  • Vaccines save lives and money
    Between 2001 and 2010, vaccine use prevented an estimated 170,000 severe pneumococcal infections and 10,000 deaths, and saved an estimated $310 million in direct medical costs each year.